TY - JOUR
T1 - Effect of non-return valves on the time-of-arrival of new medication in a patient after syringe exchange in an infusion set-up
AU - Konings, MK
AU - Gevers, Robin
AU - Mejri, Sabrine
AU - Timmerman, AMDE
N1 - Funding Information:
Research funding: This work performed under 18 HLT08 MeDDII project has received funding from the EMPIR programme co-financed by the Participating States and from the European Union’s Horizon 2020 research and innovation programme.
Publisher Copyright:
© 2022 the author(s), published by De Gruyter, Berlin/Boston.
PY - 2023/2/6
Y1 - 2023/2/6
N2 - The presence of a non-return valve in an infusion set-up is expected to affect the time-of-arrival of new medication in a patient after syringe exchange. Using Computational Fluid Dynamics (CFD) we have studied the flow through a typical non-return valve, focusing on two separate effects: (A) the overall delay in the time-of-arrival, and (B) timing effects due to the distortion of the Poiseuille flow profile in the non-return valve. The results show that (A) the additional delay in time-of-arrival of new medication, caused by the non-return valve alone, corresponds to the delay that would be caused by 11.2 cm of extra infusion line instead of the valve, and that (B) the non-Poiseuille flow profile inside the non-return valve gives rise to an extra slow wash-out of the last portion of the remnant fluid of the old medication. We conclude that awareness of these extra delays may be important for clinicians in certain time-critical situations.
AB - The presence of a non-return valve in an infusion set-up is expected to affect the time-of-arrival of new medication in a patient after syringe exchange. Using Computational Fluid Dynamics (CFD) we have studied the flow through a typical non-return valve, focusing on two separate effects: (A) the overall delay in the time-of-arrival, and (B) timing effects due to the distortion of the Poiseuille flow profile in the non-return valve. The results show that (A) the additional delay in time-of-arrival of new medication, caused by the non-return valve alone, corresponds to the delay that would be caused by 11.2 cm of extra infusion line instead of the valve, and that (B) the non-Poiseuille flow profile inside the non-return valve gives rise to an extra slow wash-out of the last portion of the remnant fluid of the old medication. We conclude that awareness of these extra delays may be important for clinicians in certain time-critical situations.
KW - CFD, dosing errors, drug delivery, infusion line, non-return valve, Poiseuille flow
KW - CFD
KW - infusion line
KW - non-return valve
KW - Poiseuille flow
KW - drug delivery
KW - dosing errors
UR - http://www.scopus.com/inward/record.url?scp=85144398828&partnerID=8YFLogxK
U2 - 10.1515/bmt-2022-0054
DO - 10.1515/bmt-2022-0054
M3 - Article
SN - 1862-278X
VL - 68
SP - 91
EP - 96
JO - Biomedical Engineering / Biomedizinische Technik (BMT)
JF - Biomedical Engineering / Biomedizinische Technik (BMT)
IS - 1
M1 - 8
ER -